Eye Clear
Eye Clear, licence 80051133: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Licence holder
- Umeken Canada, Inc.
- NPN or DIN-HM
- 80051133
- Status
- Active licence
- Licence date
- 26 May 2014
- Revision date
- Not provided
- Form
- Pilule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Conditions légales
Ginkgo biloba L.: L'étiquetage des compléments alimentaires qui contiennent la feuille de la plante Ginkgo biloba L. doit comporter un avertissement avec la teneur suivante: "Consultez votre médecin en cas de prise simultanée d'anticoagulants."
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Ipomoea batatas Source : Racine | 334.99 mg | Not calculated |
| Ginkgo biloba Source : Ginkgo biloba - feuille Extraction ratio : 50:1 Dry plant equivalent : 667 mg | 13.34 mg | Not calculated |
| Vitis Vinifera Source : Vitis vinifera - Graine Potency : 0.0 80%/4.81mg Oligomeric proanthocyanidins | 6.01 mg | Not calculated |
| Fibre de soja Source : Fibre de soja | 12.22 mg | Not calculated |
Non-medicinal ingredients
Zein, Sagoutier, glycérol, Fécule de pommes de terre, Amidon de maïs, Shellac, Maltitol
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 2.0 Pilule | 1.0 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Provides antioxidants for the maintenance of good health. Source of vitamin A for the maintenance of good health. Provitamin A for the maintenance of good health. Source of vitamin A to help maintain eyesight, skin, membranes and immune function. Provitamin A to help maintain eyesight, skin, membranes and immune function. Source of vitamin A to help in the development and maintenance of night vision. Provitamin A to help in the development and maintenance of night vision. Source of vitamin A to help in in the development and maintenance of bones. Provitamin A to help in in the development and maintenance of bones. Source of vitamin A to help in in the development and maintenance of teeth. Provitamin A to help in in the development and maintenance of teeth.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80051133
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.